iPSC Differentiation Services

iPSC-differentiated cell lines offer the perfect balance between the scalability of cell lines and the biological relevance of primary cells, making them a powerful tool for disease modeling, drug discovery, and regenerative medicine. These cells are derived from induced pluripotent stem cells (iPSCs) and can be customized to differentiate into a wide range of progenitor and lineage-specific cell types, including neural stem cells, cardiomyocytes, retinal pigment epithelial (RPE) cells, and hematopoietic progenitors.

This flexibility allows researchers to model complex human diseases more accurately, screen therapeutic compounds with greater predictive value, and explore cell-based therapies with enhanced translational potential. iPSC-derived cells are particularly valuable for studying patient-specific responses and genetic conditions, offering a personalized approach to biomedical research.

Custom differentiation services are available to support diverse research needs, enabling tailored solutions for academic, pharmaceutical, and clinical applications. Whether you're advancing basic science or developing next-generation therapies, iPSC-differentiated cell lines provide a cutting-edge platform to elevate your research.